| Name | Relationship | Address | Signature | Signature date | CIK |
|---|---|---|---|---|---|
| O'Day Steven J | Chief Medical Officer | C/O AGENUS INC., 3 FORBES ROAD, LEXINGTON | /s/Christine Klaskin, as attorney-in-fact for Steven O'Day | 2025-06-30 | 0001845281 |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | AGEN | Common Stock | Award | $194K | +43.5K | +319.38% | $4.47 | 57.1K | Jun 18, 2025 | Direct | F1, F2 |
| Id | Content |
|---|---|
| F1 | Reflects the executive's 2024 performance bonus award paid in Agenus Stock. The stock issued is fully-vested on the date of issuance but is subject to a 30-day lockup restriction with 100% of the award released on July 18, 2025. |
| F2 | $4.47 is the closing price of our Common Stock on June 18, 2025, the stock issuance date. |